Elledge RM - Search Results

1

Osborne CK, Elledge RM, Brown PH, Hilsenbeck SG. Osborne CK, et al. Among authors: elledge rm. Breast Dis. 1998 Apr;10(1-2):77-88. doi: 10.3233/bd-1998-101-210. Breast Dis. 1998. PMID: 15687551 No abstract available.

2

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.

Tham YL, Gomez LF, Mohsin S, Gutierrez MC, Weiss H, Hilsenbeck SG, Elledge RM, Chamness GC, Osborne CK, Allred DC, Chang JC. Tham YL, et al. Among authors: elledge rm. Breast Cancer Res Treat. 2005 Dec;94(3):279-84. doi: 10.1007/s10549-005-9020-z. Breast Cancer Res Treat. 2005. PMID: 16261403 Clinical Trial.

3

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Allred DC, et al. J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200. J Natl Cancer Inst. 1993. PMID: 8423624

4

Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.

Malorni L, Shetty PB, De Angelis C, Hilsenbeck S, Rimawi MF, Elledge R, Osborne CK, De Placido S, Arpino G. Malorni L, et al. Breast Cancer Res Treat. 2012 Dec;136(3):795-804. doi: 10.1007/s10549-012-2315-y. Epub 2012 Nov 4. Breast Cancer Res Treat. 2012. PMID: 23124476 Free PMC article.

5

Prognostic factors in breast cancer.

Elledge RM, McGuire WL, Osborne CK. Elledge RM, et al. Semin Oncol. 1992 Jun;19(3):244-53. Semin Oncol. 1992. PMID: 1351692 Review. No abstract available.

6

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK. Elledge RM, et al. J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705. J Natl Cancer Inst. 1994. PMID: 7908990

7

WAF1/CIP1 protein expression in human breast tumors.

Diab SG, Yu YY, Hilsenbeck SG, Allred DC, Elledge RM. Diab SG, et al. Among authors: elledge rm. Breast Cancer Res Treat. 1997 Apr;43(2):99-103. doi: 10.1023/a:1005752829260. Breast Cancer Res Treat. 1997. PMID: 9131264

8

Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.

Diab SG, Hilsenbeck SG, de Moor C, Clark GM, Osborne CK, Ravdin PM, Elledge RM. Diab SG, et al. Among authors: elledge rm. J Clin Oncol. 1998 May;16(5):1655-60. doi: 10.1200/JCO.1998.16.5.1655. J Clin Oncol. 1998. PMID: 9586875

9

p53 mutation and tamoxifen resistance in breast cancer.

Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L. Elledge RM, et al. Clin Cancer Res. 1995 Oct;1(10):1203-8. Clin Cancer Res. 1995. PMID: 9815913

10

Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.

Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Diab SG, et al. Among authors: elledge rm. J Clin Oncol. 1999 May;17(5):1442-8. doi: 10.1200/JCO.1999.17.5.1442. J Clin Oncol. 1999. PMID: 10334529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters